Learning outcomes
By the end of this lesson you should be able to: describe Virchow's triad and name its three components; outline the sequence of events in thrombosis and describe the layers of a thrombus; distinguish thrombosis from clotting in vitro; define an embolus and list its sources; predict the site of lodgement and the consequence of a pulmonary embolus; and list the available targets for pharmacological prevention.
Prerequisites
Lessons 1-4, and the haemostasis concept in the physiology course. You need vascular endothelium, platelets and coagulation to follow everything in this lesson.
The big idea
Haemostasis and thrombosis are the same machinery. When a vessel is cut, that machinery saves your life. When it forms a clot inside an intact vessel, it kills. Everything that prevents pathological clotting — antithrombotic drugs, mechanical compression, simply getting a patient up quickly after surgery — is an attempt to shift the balance of Virchow's triad, which is the framework that explains why a given patient thrombosed.
Virchow's triad
| Component | Mechanism | Clinical examples |
|---|---|---|
| Endothelial injury | Damage of the inner lining exposes collagen and tissue factor, activates platelets and the clotting cascade | Myocardial infarction and atheromatous plaque rupture, iatrogenic injury from a catheter or a valve, vasculitis, septic injury of the endothelium |
| Stasis or turbulent flow | Blood flows more slowly or swirls, so activated clotting factors are not diluted or washed away and platelets marginate | Immobilisation, long-haul flights, prolonged operations, atrial fibrillation with stasis in the atrium, aneurysms, venous obstruction |
| Hypercoagulability | The propensity of blood to clot is increased | The inherited thrombophilias (factor V Leiden, protein C or protein S deficiency, the prothrombin mutation), malignancy, oestrogen therapy and pregnancy, nephrotic syndrome, obesity, smoking |
Note which component dominates which clinical situation. Arterial and cardiac thrombi form mainly on endothelium injury — a ruptured atheromatous plaque — and are platelet-rich. Venous thrombi form mainly with stasis, and are fibrin-rich with a lot of trapped red cells. That difference is why antiplatelet drugs (aspirin, clopidogrel) prevent arterial events, and why anticoagulants (heparin, warfarin, direct oral anticoagulants) prevent venous thrombosis and thromboembolic stroke from fibrillation.
Worked example: the anatomy of a thrombus
A thrombus in a vein forms in layers, and each layer reflects a phase: a platelet head attached to the damaged endothelium, then a body of alternating platelet and fibrin layers with an appearance called the lines of Zahn, and a tail of red cells that is the part most likely to break off. Those lines of Zahn are the gross and microscopic feature that distinguishes a thrombus from post-mortem clot, which is gelatinous, layered by gravity and not adherent.
| Feature | Thrombus | Post-mortem clot |
|---|---|---|
| Attachment | Adherent to the vessel wall | Not adherent |
| Structure | Alternating platelet and fibrin lines (lines of Zahn) | Gelatinous; red cells settled by gravity (chicken fat appearance) |
| Formation | In the living, flowing circulation | After death, when flow has stopped |
The outcome of a thrombus depends on its location and on how it is handled. It may propagate along the vein, occlude, organise and be incorporated into the wall, or recanalise. It may embolise — break off and travel — and that is the dangerous outcome, because the consequences are determined by where the embolus lodges.
| Outcome | Description | Consequence |
|---|---|---|
| Propagation | The clot extends along the vessel | Worsening obstruction of the affected vein or artery |
| Embolisation | A fragment detaches and travels | Pulmonary embolism from a deep-vein thrombosis, or stroke from a carotid or cardiac source |
| Organisation and recanalisation | The clot is replaced by fibroblasts and new channels open through it | A scarred but eventually patent vein |
| Complete dissolution | Fibrinolysis clears the clot | Full restoration, usually only for a small or a recently formed clot |
Clinical correlation: venous thromboembolism
A post-operative patient, three days after a hip replacement, has a swollen, painful calf, and the following morning collapses with breathlessness, pleuritic chest pain and a raised respiratory rate. The mechanism is a chain. The immobility and the surgical injury to the veins of the leg produced a deep-vein thrombosis. A part of it broke free, entered the venous system, passed through the right heart and lodged in the pulmonary arterial tree — a pulmonary embolism.
| Clinical feature | Mechanism |
|---|---|
| Pleuritic chest pain | The embolus is at the lung periphery, against the pleural surface, and causes inflammation |
| Breathlessness and hypoxia | Blood flow to part of the lung is obstructed but ventilation continues, and the resulting dead-space ventilation wastes breathing |
| Raised respiratory rate and tachycardia | The body's compensation for a large gradient of wasted ventilation, and for the strain on the right ventricle |
| Collapse and sudden death | A large saddle embolus obstructs the outflow of the right ventricle, producing obstructive shock |
Prevention is therefore a central duty, and it is aimed directly at the triad: mobilise the patient (removes stasis), ensure adequate hydration (removes hyperviscosity), administer mechanical compression (removes stasis), and anticoagulate the patient whose risk is high enough to justify it. The clinical risk groups that warrant it — major orthopaedic surgery, major pelvic or abdominal surgery, acute illness with reduced mobility, active cancer, previous venous thromboembolism and an inherited thrombophilia — are all situations in which the triad is loaded.
Common mistakes
Watch outSaying a thrombus forms after death. It does not — the post-mortem clot is gelatinous, unattached and layered by gravity. If you see lines of Zahn or adherence to the wall, it is a thrombus and it formed in the living circulation.
Watch outSaying a pulmonary embolism comes from the systemic circulation. It comes from the venous system, so it must pass through the right heart first, and it therefore lodges in the pulmonary arteries. Systemic arterial emboli (from the left heart or the aorta) cause strokes, limb ischaemia, mesenteric ischaemia or renal infarction.
Watch outForgetting that a patient can have a deep-vein thrombosis without a swollen leg. Many emboli come from silent thrombi, which is why prophylaxis is given on the basis of risk rather than on the basis of local signs alone.
Check your understanding
What are the three components of Virchow's triad, and how would you reduce each in a patient after hip surgery?
Why does an embolus from a leg-vein thrombus cause shortness of breath rather than a stroke?
How would you tell a thrombus from a post-mortem clot?
Multiple choice
Which is NOT a component of Virchow's triad?
A mobile patient after hip surgery has a deep-vein thrombosis and then collapses. What is the most likely diagnosis?
Which feature distinguishes a thrombus from a post-mortem clot?
Why are antiplatelet drugs preferred to anticoagulants for arterial thrombosis?
Which inheritance pattern is the commonest of the inherited thrombophilias?
Which mechanism explains the breathlessness of a pulmonary embolism?
Summary and next
Thrombosis is haemostasis in the wrong place, and it is always understood through Virchow's triad: endothelial injury, stasis or turbulence, and hypercoagulability. Arterial and cardiac thrombi arise mainly from endothelial injury and are platelet-rich; venous thrombi arise mainly from stasis and are fibrin-rich. A thrombus may propagate, organise, recanalise, dissolve or embolise, and the embolus from a vein reaches the pulmonary arteries — where the resulting breathlessness and, in a large embolus, obstructive shock make pulmonary embolism one of the commonest preventable causes of post-operative death.
Next: neoplasia. You will see how the same principles — uncontrolled growth, altered blood supply, and response to therapy — describe the most feared group of diseases.